Item 1. Financial Statements
ITEM 1. FINANCIAL STATEMENTS
OSI SYSTEMS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)
(amounts in thousands, except share amounts and par value)
June 30,
March 31,
2023
2024
ASSETS
CURRENT ASSETS:
Cash and cash equivalents
$
76,750
$
101,443
Accounts receivable, net
380,845
503,828
Inventories
338,008
442,797
Prepaid expenses and other current assets
44,300
71,182
Total current assets
839,903
1,119,250
Property and equipment, net
108,933
110,399
Goodwill
349,505
352,119
Intangible assets, net
140,857
142,056
Other assets
116,488
107,251
Total assets
$
1,555,686
$
1,831,075
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES:
Bank lines of credit
$
215,000
$
349,000
Current portion of long-term debt
8,076
8,212
Accounts payable
139,011
172,115
Accrued payroll and related expenses
51,243
43,554
Advances from customers
21,250
65,888
Other accrued expenses and current liabilities
137,114
122,913
Total current liabilities
571,694
761,682
Long-term debt
136,491
131,214
Deferred income taxes
6,571
7,293
Other long-term liabilities
114,765
117,473
Total liabilities
829,521
1,017,662
Commitments and contingencies (Note 10)
STOCKHOLDERS’ EQUITY:
Preferred stock, $ 0.001 par value— 10,000,000 shares authorized; no shares issued or outstanding
—
—
Common stock, $ 0.001 par value— 100,000,000 shares authorized; issued and outstanding , 16,755,772 shares at June 30, 2023 and 17,048,704 shares at March 31, 2024
9,835
16,667
Retained earnings
735,957
816,551
Accumulated other comprehensive loss
( 19,627 )
( 19,805 )
Total stockholders’ equity
726,165
813,413
Total liabilities and stockholders’ equity
$
1,555,686
$
1,831,075
See accompanying notes to condensed consolidated financial statements.
3
Table of Contents
OSI SYSTEMS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
(amounts in thousands, except per share data)
Three Months Ended March 31,
Nine Months Ended March 31,
2023
2024
2023
2024
Net revenues:
Products
$
223,724
$
327,360
$
637,563
$
817,248
Services
79,165
78,046
228,994
240,603
Total net revenues
302,889
405,406
866,557
1,057,851
Cost of goods sold:
Products
156,534
223,570
458,197
547,938
Services
42,569
45,741
120,870
133,772
Total cost of goods sold
199,103
269,311
579,067
681,710
Gross profit
103,786
136,095
287,490
376,141
Operating expenses:
Selling, general and administrative
53,707
66,584
161,148
197,986
Research and development
14,852
17,144
43,848
49,416
Restructuring and other charges, net
890
1,004
4,366
2,496
Total operating expenses
69,449
84,732
209,362
249,898
Income from operations
34,337
51,363
78,128
126,243
Interest and other expense, net
( 5,727 )
( 7,407 )
( 14,339 )
( 19,689 )
Income before income taxes
28,610
43,956
63,789
106,554
Provision for income taxes
( 6,802 )
( 9,913 )
( 14,392 )
( 23,079 )
Net income
$
21,808
$
34,043
$
49,397
$
83,475
Earnings per share:
Basic
$
1.30
$
2.00
$
2.93
$
4.92
Diluted
$
1.27
$
1.95
$
2.88
$
4.82
Shares used in per share calculation:
Basic
16,809
17,042
16,858
16,954
Diluted
17,184
17,425
17,151
17,301
See accompanying notes to condensed consolidated financial statements.
4
Table of Contents
OSI SYSTEMS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED )
(amounts in thousands)
Three Months Ended March 31,
Nine Months Ended March 31,
2023
2024
2023
2024
Net income
$
21,808
$
34,043
$
49,397
$
83,475
Other comprehensive income (loss):
Foreign currency translation adjustment, net of tax
1,569
( 2,300 )
( 3,309 )
( 77 )
Net unrealized gain (loss) on investments and derivatives, net of tax
( 1,430 )
1,731
1,098
( 512 )
Other, net of tax
332
137
997
411
Other comprehensive income (loss)
471
( 432 )
( 1,214 )
( 178 )
Comprehensive income
$
22,279
$
33,611
$
48,183
$
83,297
See accompanying notes to condensed consolidated financial statements.
5
Table of Contents
OSI SYSTEMS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (UNAUDITED)
(amounts in thousands, except share data)
Three Months Ended March 31, 2023
Accumulated
Common Stock
Other
Number of
Retained
Comprehensive
Shares
Amount
Earnings
Loss
Total
Balance—December 31, 2022
16,819,609
$
2,530
$
672,371
$
( 27,147 )
$
647,754
Exercise of stock options
11,848
891
—
—
891
Vesting of RSUs
5,510
—
—
—
—
Shares issued under employee stock purchase program
30,652
2,072
—
—
2,072
Stock-based compensation expense
—
7,112
—
—
7,112
Repurchase of common stock
( 138,469 )
( 12,362 )
( 603 )
—
( 12,965 )
Taxes paid related to net share settlement of equity awards
( 2,029 )
( 226 )
—
—
( 226 )
Net income
—
—
21,808
—
21,808
Other comprehensive income
—
—
—
471
471
Balance—March 31, 2023
16,727,121
$
17
$
693,576
$
( 26,676 )
$
666,917
Three Months Ended March 31, 2024
Accumulated
Common Stock
Other
Number of
Retained
Comprehensive
Shares
Amount
Earnings
Loss
Total
Balance—December 31, 2023
17,011,639
$
7,308
$
782,508
$
( 19,373 )
$
770,443
Exercise of stock options
2,278
203
—
—
203
Vesting of RSUs
4,428
—
—
—
—
Shares issued under employee stock purchase program
31,968
2,296
—
—
2,296
Stock-based compensation expense
—
7,069
—
—
7,069
Taxes paid related to net share settlement of equity awards
( 1,609 )
( 209 )
—
—
( 209 )
Net income
—
—
34,043
—
34,043
Other comprehensive loss
—
—
—
( 432 )
( 432 )
Balance—March 31, 2024
17,048,704
$
16,667
$
816,551
$
( 19,805 )
$
813,413
6
Table of Contents
OSI SYSTEMS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (UNAUDITED)
(amounts in thousands, except share data)
Nine Months Ended March 31, 2023
Accumulated
Common Stock
Other
Number of
Retained
Comprehensive
Shares
Amount
Earnings
Loss
Total
Balance—June 30, 2022
16,870,050
$
17
$
663,869
$
( 25,462 )
$
638,424
Exercise of stock options
19,614
1,330
—
—
1,330
Vesting of RSUs
312,038
—
—
—
—
Shares issued under employee stock purchase program
59,255
4,041
—
—
4,041
Stock-based compensation expense
—
21,528
—
—
21,528
Repurchase of common stock
( 400,230 )
( 17,067 )
( 17,682 )
—
( 34,749 )
Taxes paid related to net share settlement of equity awards
( 133,606 )
( 9,832 )
( 2,008 )
—
( 11,840 )
Net income
—
—
49,397
—
49,397
Other comprehensive loss
—
—
—
( 1,214 )
( 1,214 )
Balance—March 31, 2023
16,727,121
$
17
$
693,576
$
( 26,676 )
$
666,917
Nine Months Ended March 31, 2024
Accumulated
Common Stock
Other
Number of
Retained
Comprehensive
Shares
Amount
Earnings
Loss
Total
Balance—June 30, 2023
16,755,772
$
9,835
$
735,957
$
( 19,627 )
$
726,165
Exercise of stock options
16,767
1,387
—
—
1,387
Vesting of RSUs
389,042
—
—
—
—
Shares issued under employee stock purchase program
61,781
4,327
—
—
4,327
Stock-based compensation expense
—
21,486
—
—
21,486
Taxes paid related to net share settlement of equity awards
( 174,658 )
( 20,368 )
( 2,881 )
—
( 23,249 )
Net income
—
—
83,475
—
83,475
Other comprehensive loss
—
—
—
( 178 )
( 178 )
Balance—March 31, 2024
17,048,704
$
16,667
$
816,551
$
( 19,805 )
$
813,413
7
Table of Contents
OSI SYSTEMS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
(amounts in thousands)
Nine Months Ended March 31,
2023
2024
CASH FLOWS FROM OPERATING ACTIVITIES
Net income
$
49,397
$
83,475
Adjustments to reconcile net income to net cash provided by (used in) operating activities, net of effects from acquisitions:
Depreciation and amortization
28,819
30,485
Stock-based compensation expense
21,528
21,486
Provision for (recovery of) losses on accounts receivable
( 4,890 )
2,059
Deferred income taxes
942
( 524 )
Amortization of debt discount and issuance costs
196
—
Other
( 46 )
10
Changes in operating assets and liabilities—net of business acquisitions:
Accounts receivable
13,248
( 118,989 )
Inventories
( 37,860 )
( 101,446 )
Prepaid expenses and other assets
( 4,924 )
( 41,503 )
Accounts payable
2,134
32,933
Accrued payroll and related expenses
2,151
( 8,155 )
Advances from customers
13,963
43,805
Deferred revenue
11,101
3,105
Other
( 23,081 )
( 5,199 )
Net cash provided by (used in) operating activities
72,678
( 58,458 )
CASH FLOWS FROM INVESTING ACTIVITIES
Acquisition of property and equipment
( 12,691 )
( 13,604 )
Proceeds from sale of property and equipment
309
293
Purchases of certificates of deposit
( 4,940 )
—
Proceeds from maturities of certificates of deposit
3,827
10,329
Acquisition of businesses, net of cash acquired
( 4,616 )
( 9,046 )
Payments for intangible and other assets
( 12,275 )
( 12,906 )
Net cash used in investing activities
( 30,386 )
( 24,934 )
CASH FLOWS FROM FINANCING ACTIVITIES
Net borrowings on bank lines of credit
155,000
134,000
Proceeds from long-term debt
100,654
1,110
Payments on long-term debt
( 247,818 )
( 6,248 )
Proceeds from exercise of stock options and employee stock purchase plan
5,371
5,714
Payments of contingent consideration
( 3,668 )
( 602 )
Repurchases of common stock
( 34,749 )
—
Taxes paid related to net share settlement of equity awards
( 11,840 )
( 23,249 )
Net cash (used in) provided by financing activities
( 37,050 )
110,725
Effect of exchange rate changes on cash
( 3,822 )
( 2,640 )
Net change in cash and cash equivalents
1,420
24,693
Cash and cash equivalents—beginning of period
64,202
76,750
Cash and cash equivalents—end of period
$
65,622
$
101,443
Supplemental disclosure of cash flow information:
Cash paid, net during the period for:
Interest
$
14,648
$
18,868
Income taxes
$
15,769
$
33,703
See accompanying notes to condensed consolidated financial statements.
8
Table of Contents
OSI SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
1. Basis of Presentation
The condensed consolidated financial statements include the accounts of OSI Systems, Inc. and our subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. The condensed consolidated financial statements have been prepared by management in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and in conjunction with the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures required for annual financial statements have been condensed or excluded in accordance with SEC rules and regulations and GAAP applicable to interim unaudited financial statements. Accordingly, the condensed consolidated financial statements do not include all information and footnotes required by GAAP for audited annual financial statements. In management’s opinion, the condensed consolidated financial statements reflect all adjustments of a normal and recurring nature that are considered necessary for a fair presentation of the results for the interim periods presented. These unaudited condensed consolidated financial statements and the accompanying notes should be read in conjunction with the audited consolidated financial statements and accompanying notes included in our Annual Report on Form 10-K for the fiscal year ended June 30, 2023 filed with the SEC. The results of operations for the three and nine months ended March 31, 2024 are not necessarily indicative of the operating results to be expected for the full 2024 fiscal year or any future periods.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of sales, costs of sales and expenses during the reporting period. The most significant of these estimates and assumptions for our company relate to contract revenue, fair values of assets acquired and liabilities assumed in business combinations, values for inventories reported at lower of cost or net realizable value, stock-based compensation expense, income taxes, accrued warranty costs, contingent consideration, allowance for doubtful accounts, and the recoverability, useful lives and valuation of recorded amounts of long-lived assets, identifiable intangible assets and goodwill. Changes in estimates are reflected in the periods during which they become known. Due to the inherent uncertainty involved in making estimates, our actual amounts reported in future periods could differ materially from these estimates.
Earnings Per Share Computations
We compute basic earnings per share by dividing net income available to common stockholders by the weighted average number of common shares outstanding during the period. We compute diluted earnings per share by dividing net income available to common stockholders by the sum of the weighted average number of common shares and dilutive potential common shares outstanding during the period. Potential common shares consist of the shares issuable upon the exercise of stock options and restricted stock unit awards under the treasury stock method.
The following table sets forth the computation of basic and diluted earnings per share (in thousands, except per share amounts):
Three Months Ended March 31,
Nine Months Ended March 31,
2023
2024
2023
2024
Net income available to common stockholders
$
21,808
$
34,043
$
49,397
$
83,475
Weighted average shares outstanding—basic
16,809
17,042
16,858
16,954
Dilutive effect of equity awards
375
383
293
347
Weighted average shares outstanding—diluted
17,184
17,425
17,151
17,301
Basic earnings per share
$
1.30
$
2.00
$
2.93
$
4.92
Diluted earnings per share
$
1.27
$
1.95
$
2.88
$
4.82
Shares excluded from diluted earnings per share due to their anti-dilutive effect
60
22
75
11
9
Table of Contents
Cash and Cash Equivalents
We consider all highly liquid investments with maturities of three months or less as of the acquisition date to be cash equivalents.
Our cash and cash equivalents totaled $ 101.4 million at March 31, 2024. Of this amount, approximately 78 % was held by our foreign subsidiaries and subject to repatriation tax considerations. These foreign funds were held primarily by our subsidiaries in India, the United Kingdom, Malaysia, Singapore, Australia, and Canada and to a lesser extent in Mexico, Albania, Indonesia and Germany, among other countries. We have cash holdings in financial institutions that exceed insured limits for such financial institutions; however, we mitigate this risk by utilizing international financial institutions which we believe to be of high credit quality.
Fair Value of Financial Instruments
Our financial instruments consist primarily of cash and cash equivalents, insurance company contracts, accounts receivable, accounts payable, debt instruments, an interest rate swap contract and foreign currency forward contracts. The carrying values of financial instruments, other than long-term debt instruments and our interest rate swap contract, are representative of their fair values due to their short-term maturities. The carrying values of our long-term debt instruments are considered to approximate their fair values because the interest rates of these instruments are variable or comparable to current rates for financing available to us. The fair values of our foreign currency forward contracts were not significant as of June 30, 2023 and March 31, 2024.
Fair value is the price that would be received in the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The “Level 1” category comprises assets and liabilities measured at quoted prices in active markets for identical assets and liabilities. The “Level 2” category comprises assets and liabilities measured from observable inputs other than quoted market prices. The “Level 3” category comprises assets and liabilities for which valuation inputs are unobservable and significant to the fair value measurement. Our contingent payment obligations related to acquisitions, which are further discussed in Note 10 to the condensed consolidated financial statements, are in the “Level 3” category for valuation purposes.
The fair values of our financial assets and liabilities are categorized as follows (in thousands):
June 30, 2023
March 31, 2024
Level 1
Level 2
Level 3
Total
Level 1
Level 2
Level 3
Total
Assets—Insurance company contracts
$
—
$
47,181
$
—
$
47,181
$
—
$
48,982
$
—
$
48,982
Assets – Interest rate swap contract
$
—
$
5,369
$
—
$
5,369
$
—
$
4,660
$
—
$
4,660
Liabilities—Contingent consideration
$
—
$
—
$
21,181
$
21,181
$
—
$
—
$
18,888
$
18,888
Derivative Instruments and Hedging Activity
Our use of derivatives consists of foreign currency forward contracts and an interest rate swap agreement. Our foreign currency forward contracts are utilized to partially mitigate certain balance sheet exposures or used as a net investment hedge to protect against potential changes resulting from short-term foreign currency fluctuations. These contracts have original maturities of up to three months. We also manage our risk to changes in interest rates using derivative instruments. We use fixed interest rate swaps to effectively convert a portion of the variable interest rate payments to fixed interest rate payments. We do not use hedging instruments for speculative purposes.
The net gains or losses from our foreign currency forward contracts, which are not designated as hedge instruments, are reported in our consolidated statements of operations. The amounts reported in the consolidated statements of operations for the three and nine months ended March 31, 2023 and 2024 were not significant. The fair value of our foreign currency forward contracts is estimated using a standard valuation model and market-based observable inputs over the contractual term. Unrealized gains are recognized as assets and unrealized losses are recognized as liabilities. As of June 30, 2023 and March 31, 2024, we held foreign currency forward contracts with notional amounts totaling $ 21.6 million and $ 57.3 million, respectively. Unrealized gains and losses from our foreign currency forward contracts as of June 30, 2023 and March 31, 2024 were not significant.
10
Table of Contents
The interest rate swap agreement was entered into to improve the predictability of cash flows from interest payments related to our variable, Secured Overnight Financing Rate (“SOFR”) based debt. The interest rate swap matures in December 2026. The interest rate swap is considered an effective cash flow hedge, and as a result, the net gains or losses on such instrument are reported as a component of other comprehensive income (loss) in our consolidated financial statements and are reclassified as net income when the underlying hedged interest impacts earnings. A qualitative and quantitative assessment of the interest rate swap hedge effectiveness is performed on a quarterly basis, unless facts and circumstances indicate that the hedge may no longer be highly effective.
As of June 30, 2023 and March 31, 2024, the notional amount of the interest rate swap hedge derivative instrument was $ 175 million. The fair value of the interest rate swap contract as of June 30, 2023 and March 31, 2024 is recorded in Other assets within the consolidated balance sheet.
The effect of the cash flow hedges on other comprehensive income (loss) and earnings for the periods presented was as follows:
Three Months Ended March 31,
Nine Months Ended March 31,
2023
2024
2023
2024
Total interest and other expense, net presented in the condensed consolidated statements of operations in which the effects of cash flow hedges are recorded
$
( 5,727 )
$
( 7,407 )
$
( 14,339 )
$
( 19,689 )
Gain (loss) recognized in other comprehensive income (loss), net of tax
$
( 1,430 )
$
( 1,732 )
$
1,098
$
512
Amount reclassified from accumulated other comprehensive income (loss) to interest expense, net
$
543
$
897
$
587
$
2,681
Recent Accounting Pronouncements
From time to time, new accounting pronouncements are issued by the FASB and other regulatory bodies that are adopted as of the specified effective dates. Unless otherwise discussed below, management believes that the impact of recently issued standards, which are not yet effective for the Company, will not have a material impact on our Consolidated Financial Statements upon adoption. There were no new pronouncements adopted in the third quarter of fiscal year 2024.
In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update 2023-07, “Improvements to Reportable Segment Disclosures” (“ASU 2023-07”), which requires disclosures of significant expenses by segment and interim disclosure of items that were previously required on an annual basis. ASU 2023-07 is to be applied on a retrospective basis and is effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024 with early adoption permitted. We are evaluating the impact of ASU 2023-07 on disclosures in our Consolidated Financial Statements.
In December 2023, the FASB issued Accounting Standards Update 2023-09, “Improvements to Income Tax Disclosures” (“ASU 2023-09”), which provides for additional disclosures primarily related to the income tax rate reconciliations and income taxes paid. ASU 2023-09 requires entities to annually disclose the income tax rate reconciliation using both amounts and percentages, considering several categories of reconciling items, including state and local income taxes, foreign tax effects, tax credits and nontaxable or nondeductible items, among others. Disclosure of the reconciling items is subject to a quantitative threshold and disaggregation by nature and jurisdiction. ASU 2023-09 also requires entities to disclose net income taxes paid or received to federal, state and foreign jurisdictions, as well as by individual jurisdiction, subject to a five percent quantitative threshold. ASU 2023-09 may be adopted on a prospective or retrospective basis and is effective for fiscal years beginning after December 15, 2024 with early adoption permitted. We are evaluating the impact of ASU 2023-09 on disclosures in our Consolidated Financial Statements.
11
Table of Contents
2. Business Combinations
Under Accounting Standards Codification Topic 805, Business Combinations (“ASC 805”), the acquisition method of accounting requires us to record assets acquired less liabilities assumed from an acquisition at their estimated fair values at the date of acquisition. Any excess of the total estimated purchase price over the estimated fair value of the net assets acquired should be recorded as goodwill. Such valuations require management to make significant estimates and assumptions, especially with respect to intangible assets. Significant estimates in valuing certain intangible assets include, but are not limited to, future expected cash flows from acquired customers, acquired technology, trade names, useful lives and discount rates. Management’s estimates of fair value are based upon assumptions which are believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates. During the measurement period, which is up to one year from the acquisition date, as additional information that existed at the acquisition date becomes available for preliminary estimates, we may record adjustments to the preliminary assets acquired and liabilities assumed. Upon the conclusion of the measurement period, any subsequent adjustments are included in earnings.
Fiscal Year 2024 Business Acquisitions
In December 2023, we (through our Optoelectronics and Manufacturing division) acquired a privately held contract manufacturer for approximately $ 6.3 million. The acquisition was financed with cash on hand. The goodwill recognized for this business acquisition is deductible for income tax purposes.
In October 2023, we (through our Security division) acquired a privately held provider of radiation detection technology for approximately $ 2.8 million, plus up to $ 3.6 million in potential contingent consideration. The acquisition was financed with cash on hand. The goodwill recognized for this business acquisition is not deductible for income tax purposes.
Fiscal Year 2023 Business Acquisitions
In April 2023, we (through our Optoelectronics and Manufacturing division) acquired a privately held provider of engineering and contract manufacturing solutions for approximately $ 2.5 million, plus up to $ 2.5 million in potential contingent consideration. The acquisition was financed with cash on hand.
In February 2023, we (through our Healthcare division) acquired a privately held provider of software and solutions for approximately $ 2.1 million plus up to $ 5.0 million in potential contingent consideration. The acquisition was financed with cash on hand.
Through our Security division, we acquired (i) in December 2022 certain assets of a provider of baggage and parcel inspection systems for approximately $ 1.6 million and (ii) in August 2022 a privately held provider of training software and solutions for approximately $ 1.9 million plus an immaterial amount of potential contingent consideration. These acquisitions were financed with cash on hand.
The goodwill we recognized for each of the fiscal year 2023 business acquisitions is not deductible for income tax purposes. The acquisitions we completed in fiscal 2023 and 2024, individually and in the aggregate, were not material to our consolidated financial statements. Accordingly, pro-forma historical results of operations and other disclosures related to these businesses have not been presented.
12
Table of Contents
3. Balance Sheet Details
The following tables set forth details of selected balance sheet accounts (in thousands):
June 30,
March 31,
Accounts receivable, net
2023
2024
Accounts receivable
$
395,218
$
519,476
Less allowance for doubtful accounts
( 14,373 )
( 15,648 )
Total
$
380,845
$
503,828
June 30,
March 31,
Inventories
2023
2024
Raw materials
$
233,217
$
257,846
Work-in-process
56,329
88,323
Finished goods
48,462
96,628
Total
$
338,008
$
442,797
June 30,
March 31,
Property and equipment, net
2023
2024
Land
$
15,691
$
15,524
Buildings, civil works and improvements
49,166
48,648
Leasehold improvements
13,553
13,642
Equipment and tooling
135,703
142,962
Furniture and fixtures
3,632
3,397
Computer equipment
24,119
22,367
Computer software
26,981
30,532
Computer software implementation in process
9,705
6,212
Construction in process
4,108
6,137
Total
282,658
289,421
Less accumulated depreciation and amortization
( 173,725 )
( 179,022 )
Property and equipment, net
$
108,933
$
110,399
Depreciation and amortization expense for property and equipment was $ 4.9 million and $ 5.1 million for the three months ended March 31, 2023 and 2024, respectively, and $ 14.6 million for each of the nine months ended March 31, 2023 and 2024.
4. Goodwill and Intangible Assets
The changes in the carrying value of goodwill by segment for the nine-month period ended March 31, 2024 were as follows (in thousands):
Optoelectronics
And
Security
Manufacturing
Healthcare
Division
Division
Division
Consolidated
Balance as of June 30, 2023
$
230,662
$
70,388
$
48,455
$
349,505
Goodwill acquired
2,072
828
—
2,900
Foreign currency translation adjustment
25
( 310 )
( 1 )
( 286 )
Balance as of March 31, 2024
$
232,759
$
70,906
$
48,454
$
352,119
13
Table of Contents
Intangible assets consisted of the following (in thousands):
June 30, 2023
March 31, 2024
Gross
Gross
Carrying
Accumulated
Intangibles
Carrying
Accumulated
Intangibles
Value
Amortization
Net
Value
Amortization
Net
Amortizable assets:
Software development costs
$
77,844
$
( 20,285 )
$
57,559
$
86,576
$
( 19,986 )
$
66,590
Patents
8,636
( 3,404 )
5,232
9,003
( 3,745 )
5,258
Developed technology
68,274
( 38,353 )
29,921
71,208
( 44,174 )
27,034
Customer relationships
55,780
( 39,101 )
16,679
51,536
( 39,894 )
11,642
Total amortizable assets
210,534
( 101,143 )
109,391
218,323
( 107,799 )
110,524
Non-amortizable assets:
In-process R&D
533
—
533
—
—
—
Trademarks
30,933
—
30,933
31,532
—
31,532
Total intangible assets
$
242,000
$
( 101,143 )
$
140,857
$
249,855
$
( 107,799 )
$
142,056
Amortization expense related to intangible assets was $ 4.8 million and $ 5.5 million for the three months ended March 31, 2023 and 2024, respectively. For the nine months ended March 31, 2023 and 2024, amortization expense related to intangible assets was $ 14.2 million and $ 15.9 million, respectively.
At March 31, 2024, the estimated future amortization expense for intangible assets was as follows (in thousands):
Fiscal Year
2024 (remaining 3 months)
$
4,922
2025
16,299
2026
12,704
2027
8,522
2028
5,659
Thereafter
62,418
Total
$
110,524
Software development costs for software products incurred before establishing technological feasibility are charged to operations. Software development costs incurred after establishing technological feasibility are capitalized on a product-by-product basis until the product is available for general release to customers at which time amortization begins. Annual amortization, charged to cost of goods sold, is the amount computed using the ratio of current revenues for a product compared to the total current and anticipated future revenues for that product. In the event that future revenues are not estimable, such costs are amortized on a straight-line basis over the remaining estimated economic life of the product. Amortizable assets that have not yet begun to be amortized are included in Thereafter in the table above. For the three months ended March 31, 2023 and 2024, we capitalized software development costs in the amounts of $ 4.1 million and $ 4.3 million, respectively. For the nine months ended March 31, 2023 and 2024, we capitalized software development costs in the amounts of $ 12.0 million and $ 12.3 million, respectively.
5. Contract Assets and Liabilities
We enter into contracts to sell products and provide services, and we recognize contract assets and liabilities that arise from these transactions. We recognize revenue and corresponding accounts receivable according to ASC Topic 606, Revenue from Contracts with Customers (“ASC 606”). When we recognize revenue in advance of the point in time at which contracts give us the right to invoice a customer, we record this as unbilled revenue, which is included in accounts receivable, net, on the consolidated balance sheets. We may also receive consideration, per the terms of a contract, from customers prior to transferring control of goods to the customer. We record customer deposits as contract liabilities. Additionally, we may receive payments, most typically under service and warranty contracts, at the onset of a contract and before services have been performed. In such instances, we record a deferred revenue liability in either Other accrued expenses and current liabilities or Other long-term liabilities. We recognize these contract liabilities as sales after all revenue recognition criteria are met.
14
Table of Contents
The table below shows the balance of contract assets and liabilities as of June 30, 2023 and March 31, 2024, including the change between the periods. There were no substantial non-current contract assets for the periods presented.
Contract Assets (in thousands)
June 30,
March 31,
2023
2024
Change
% Change
Unbilled revenue (included in accounts receivable, net)
$
86,818
$
241,092
$
154,274
178
%
Contract Liabilities (in thousands),
June 30,
March 31,
2023
2024
Change
% Change
Advances from customers
$
21,250
$
65,888
$
44,638
210
%
Deferred revenue—current
43,861
45,779
1,918
4
Deferred revenue—long-term
22,200
23,446
1,246
6
Contract assets increased during the nine months ended March 31, 2024, primarily from the timing and nature of milestones met in contracts for a number of customers in our Security division where we met the revenue recognition criteria under ASC 606 in advance of the time when contracts give us the right to invoice customers. The net increase in contract liabilities was primarily due to activity in our Security division for deposits received on contracts, partially offset by recognition of revenue on service contracts included in deferred revenue.
Remaining Performance Obligations . Remaining performance obligations related to ASC 606 represent the portion of the transaction price allocated to performance obligations under an original contract with a term greater than one year which are fully or partially unsatisfied at the end of the applicable period. As of March 31, 2024, the portion of the transaction price allocated to remaining performance obligations was approximately $ 925.1 million. We expect to recognize revenue on approximately 57 % of the remaining performance obligations over the next 12 months , and the remainder is expected to be recognized thereafter. During the nine months ended March 31, 2024, we recognized revenue of $ 53.6 million from contract liabilities existing at the beginning of the period.
Practical Expedients. In cases where we are responsible for shipping after the customer has obtained control of the goods, we have elected to treat the shipping activity as a fulfillment activity rather than as a separate performance obligation. Additionally, we have elected to capitalize the cost to obtain a contract only if the period of amortization is longer than one year. We only give consideration to whether a customer agreement has a financing component if the period of time between transfer of goods and services and customer payment is greater than one year.
6. Leases
The components of operating lease expense were as follows (in thousands):
Three Months Ended March 31,
Nine Months Ended March 31,
2023
2024
2023
2024
Operating lease cost
$
2,850
$
2,822
$
8,525
$
8,433
Variable lease cost
328
289
1,055
823
Short-term lease cost
261
372
685
1,038
$
3,439
$
3,483
$
10,265
$
10,294
15
Table of Contents
Supplemental disclosures related to operating leases were as follows (in thousands):
Balance Sheet Category
June 30, 2023
March 31, 2024
Operating lease ROU assets, net
Other assets
$
32,618
$
28,792
Operating lease liabilities, current portion
Other accrued expenses and current liabilities
$
9,787
$
9,373
Operating lease liabilities, long-term
Other long-term liabilities
23,733
20,141
Total operating lease liabilities
$
33,520
$
29,514
Weighted average remaining lease term
3.8 years
Weighted average discount rate
4.1
%
Supplemental cash flow information related to operating leases was as follows (in thousands):
Nine Months Ended March 31,
2023
2024
Cash paid for operating lease liabilities
$
8,631
$
9,114
ROU assets obtained in exchange for new lease obligations
2,658
3,780
Maturities of operating lease liabilities at March 31, 2024 were as follows (in thousands):
March 31, 2024
Less than one year
$
10,344
1 – 2 years
8,894
2 – 3 years
7,754
3 – 4 years
4,230
4 – 5 years
934
Thereafter
278
32,434
Less: imputed interest
( 2,920 )
Total lease liabilities
$
29,514
7. Restructuring and Other Charges
We endeavor to align our global capacity and infrastructure with demand by our customers as well as fully integrate acquisitions and thereby improve operational efficiency.
During the three months ended March 31, 2024, we recognized $ 1.0 million in restructuring and other charges, which primarily included $ 0.5 million for facility closure costs for operational efficiency activities, and $ 0.5 million for employee terminations. During the nine months ended March 31, 2024, we recognized $ 2.5 million in restructuring and other charges, which included $ 0.8 million for facility closure costs for operational efficiency activities , $ 0.8 million for employee terminations, $ 0.4 million in acquisition related costs, and $ 0.4 million in legal charges.
During the three months ended March 31, 2023, we recognized $ 0.9 million in restructuring and other charges, which included $ 0.5 million for employee terminations, $ 0.3 million in legal charges primarily related to government investigations, and $ 0.1 million in acquisition - related costs and facility closure costs. During the nine months ended March 31, 2023, we recognized $ 4.4 million in restructuring and other charges, which included $ 3.2 million in legal charges primarily related to class action litigation and government investigations, $ 1.0 million for employee terminations, and $ 0.2 million in acquisition-related costs and facility closure costs.
16
Table of Contents
The following tables summarize restructuring and other charges (benefits), net for the periods set forth below (in thousands):
Three Months Ended March 31, 2023
Optoelectronics and
Manufacturing
Healthcare
Security Division
Division
Division
Corporate
Total
Acquisition-related costs
$
—
$
—
$
—
$
50
$
50
Employee termination costs
413
32
81
—
526
Facility closures/consolidation
35
—
—
—
35
Legal costs, net
45
—
226
8
279
Total
$
493
$
32
$
307
$
58
$
890
Three Months Ended March 31, 2024
Optoelectronics and
Manufacturing
Healthcare
Security Division
Division
Division
Corporate
Total
Acquisition-related costs
$
8
$
11
$
—
$
—
$
19
Employee termination costs
129
60
311
2
502
Facility closures/consolidation
38
433
—
—
471
Legal costs, net
10
—
—
2
12
Total
$
185
$
504
$
311
$
4
$
1,004
Nine Months Ended March 31, 2023
Optoelectronics and
Manufacturing
Healthcare
Security Division
Division
Division
Corporate
Total
Acquisition-related costs
$
23
$
—
$
—
$
127
$
150
Employee termination costs
688
47
291
—
1,026
Facility closures/consolidation
35
—
—
—
35
Legal costs, net
612
—
2,462
81
3,155
Total
$
1,358
$
47
$
2,753
$
208
$
4,366
Nine Months Ended March 31, 2024
Optoelectronics and
Manufacturing
Healthcare
Security Division
Division
Division
Corporate
Total
Acquisition-related costs
$
243
$
201
$
—
$
—
$
444
Employee termination costs
279
102
311
122
814
Facility closures/consolidation
38
777
—
—
815
Legal costs, net
61
—
—
362
423
Total
$
621
$
1,080
$
311
$
484
$
2,496
17
Table of Contents
The accrued liability for restructuring and other charges is included in other accrued expenses and current liabilities in the condensed consolidated balance sheets. The changes in the accrued liability for restructuring and other charges for the nine-month period ended March 31, 2024 were as follows (in thousands):
Facility
Acquisition-
Employee
Closure/
Legal
Related
Termination
Consolidation
Costs and
Costs
Costs
Cost
Settlements
Total
Balance as of June 30, 2023
$
7
$
107
$
1,609
$
656
$
2,379
Restructuring and other charges, net
444
814
815
423
2,496
Payments, adjustments and reimbursements, net
( 451 )
( 750 )
( 2,082 )
( 622 )
( 3,905 )
Balance as of March 31, 2024
$
—
$
171
$
342
$
457
$
970
8. Borrowings
Revolving Credit Facility
Our senior secured credit facility comprises a term loan and a $ 600 million revolving credit facility which mature in December 2026. The revolving credit facility includes a $ 300 million sub-limit for letters of credit. Under certain circumstances and subject to certain conditions, we have the ability to increase the revolving credit facility by an amount equal to the greater of $ 250 million or such amount as would not cause our secured leverage ratio to exceed a specified level. Borrowings under the facility bear interest at SOFR plus a margin of 1.0 % as of March 31, 2024 (which margin can range from 1.0 % to 1.75 % based on our consolidated net leverage ratio as defined in the credit facility). Letters of credit reduce the amount available to borrow under the credit facility by their face value amount. The unused portion of the facility bears a commitment fee of 0.10 % as of March 31, 2024 (which fee can range from 0.10 % to 0.25 % based on our consolidated net leverage ratio as defined in the credit facility). Our borrowings under the credit agreement are guaranteed by certain of our U.S.-based subsidiaries and are secured by substantially all of our assets and substantially all the assets of certain of our subsidiaries. The credit facility contains various representations and warranties, affirmative, negative and financial covenants and events of default. As of March 31, 2024, there were $ 349.0 million of borrowings outstanding under the revolving credit facility, $ 74.7 million outstanding under the letters of credit sub-facility, and $ 137.5 million outstanding under the term loan. As of March 31, 2024, the amount available to borrow under the revolving credit facility was $ 176.3 million. Loan amounts under the revolving credit facility may be borrowed, repaid and re-borrowed during the term. The principal amount of each loan is due and payable in full on the maturity date. We have the right to repay each loan in whole or in part from time to time without penalty. It is our practice to routinely borrow and repay several times per year under the revolving facility and therefore, borrowings under the revolving credit facility are included in current liabilities. As of March 31, 2024, we were in compliance with all financial covenants under this credit facility. In September 2022, we entered into an interest rate swap in order to mitigate the interest rate risk on a portion of the interest payments expected to be made on the borrowings outstanding under the revolving credit facility and term loan. Refer to Note 1 for details. Interest expense related to the credit facility and term loan was $ 5.9 million and $ 8.1 million for the three months ended March 31, 2023 and 2024, respectively, and $ 12.9 million and $ 21.5 million for the nine months ended March 31, 2023 and 2024, respectively.
1.25% Convertible Senior Notes (“Notes”) Due 2022
In February 2017, we issued $ 287.5 million of the Notes in a private offering. On September 1, 2022, we repurchased and cancelled the then - remaining $ 242.3 million balance of the Notes. Total interest expense recognized, through the cancellation date, during the nine months ended March 31, 2023 related to the Notes was $ 0.7 million, which consisted of $ 0.5 million of contractual interest expense and $ 0.2 million of amortization of debt issuance costs.
Other Borrowings
Several of our foreign subsidiaries maintain bank lines of credit, denominated in local currencies and U.S. dollars, primarily for the issuance of letters of credit. As of March 31, 2024, $ 54.5 million was outstanding under these letter-of-credit facilities. As of March 31, 2024, the total amount available under these credit facilities was $ 21.4 million.
18
Table of Contents
Long-term debt consisted of the following (in thousands):
June 30,
March 31,
2023
2024
Term loan
$
143,125
$
137,500
Other long-term debt
1,442
1,926
144,567
139,426
Less current portion of long-term debt
( 8,076 )
( 8,212 )
Long-term portion of debt
$
136,491
$
131,214
9. Stockholders’ Equity
Stock-based Compensation
As of March 31, 2024, we maintained the Amended and Restated 2012 Incentive Award Plan (the “OSI Plan”) as a stock-based employee compensation plan.
We recorded stock-based compensation expense in the consolidated statements of operations as follows (in thousands):
Three Months Ended March 31,
Nine Months Ended March 31,
2023
2024
2023
2024
Cost of goods sold
$
229
$
214
$
686
$
701
Selling, general and administrative
6,757
6,650
20,467
20,326
Research and development
126
205
375
459
Stock-based compensation expense
$
7,112
$
7,069
$
21,528
$
21,486
As of March 31, 2024, total unrecognized compensation cost related to share-based compensation grants under the OSI Plan were estimated at $ 1.0 million for stock options and $ 15.6 million for restricted stock units (“RSUs”). We expect to recognize these costs over a weighted average period of 2.2 years with respect to the stock options and 2.2 years with respect to the RSUs.
The following summarizes stock option activity during the nine months ended March 31, 2024:
Weighted
Average
Weighted-Average
Aggregate
Number of
Exercise
Remaining Contractual
Intrinsic Value
Options
Price
Term
(in thousands)
Outstanding at June 30, 2023
83,677
$
87.09
Granted
22,438
119.45
Exercised
( 16,767 )
82.90
Expired or forfeited
( 4,375 )
86.09
Outstanding at March 31, 2024
84,973
$
96.51
7.5 years
$
3,935
Exercisable at March 31, 2024
40,578
5.8 years
$
2,264
The following summarizes RSU award activity during the nine months ended March 31, 2024:
Weighted-
Average
Shares
Fair Value
Nonvested at June 30, 2023
455,515
$
85.15
Granted
333,001
95.41
Vested
( 389,042 )
79.75
Forfeited
( 5,253 )
84.59
Nonvested at March 31, 2024
394,221
$
99.16
19
Table of Contents
In December 2023, our shareholders approved an amendment to the OSI Plan, which increased the shares available under the OSI Plan by 2.4 million shares. As of March 31, 2024, there were approximately 2.5 million shares available for grant under the OSI Plan. Under the terms of the OSI Plan, RSUs and restricted stock granted from the pool of shares available for grant reduce the pool by 1.87 shares for each award granted. RSUs and restricted stock forfeited and returned to the pool of shares available for grant increase the pool by 1.87 shares for each award forfeited.
We granted 110,811 and 75,988 performance-based RSUs during the nine months ended March 31, 2023 and 2024, respectively. These performance-based RSU awards are contingent on the achievement of certain performance metrics. The payout related to these awards can range from zero to 376 % of the original number of shares or units awarded. Compensation cost associated with these performance-based RSUs are recognized based on the estimated number of shares that we ultimately expect will vest. If the estimated number of shares to vest is revised in the future, then stock-based compensation expense will be adjusted accordingly.
Stock Repurchase Program
In September 2022, our Board of Directors increased the stock repurchase authorization to a total of 2 million shares. This program does not expire unless our Board of Directors acts to terminate the program. The timing and actual numbers of shares purchased depend on a variety of factors, including stock price, general business and market conditions and other investment opportunities. Repurchases may be made from time to time under the program through open-market purchases or privately-negotiated transactions at our discretion. Upon repurchase, the shares are restored to the status of authorized but unissued shares, and we record them in our consolidated financial statements as a reduction in the number of shares of common stock issued and outstanding, with the excess purchase price over par value recorded as a reduction of additional paid-in capital. If additional paid-in capital is reduced to zero, we record the remainder of the excess purchase price over par value as a reduction of retained earnings.
During the nine months ended March 31, 2024, we did not repurchase shares of our common stock. As of March 31, 2024, there were 1,721,870 shares remaining available for repurchase under the authorized repurchase program.
Dividends
We have not paid any cash dividends since the consummation of our initial public offering in 1997 and we do not currently intend to pay any cash dividends in the foreseeable future. Our Board of Directors will determine the payment of future cash dividends, if any. Certain of our current bank credit facilities restrict the payment of cash dividends and future borrowings may contain similar restrictions.
10. Commitments and Contingencies
Acquisition-Related Contingent Obligations
Under the terms and conditions of the purchase agreements associated with certain acquisitions, we may be obligated to make additional payments based on the achievement of certain sales or profitability milestones through the acquired operations. For agreements that contain contingent consideration obligations that are capped, the remaining maximum amount of such potential future payments is $ 48.6 million as of March 31, 2024.
Projections and estimated probabilities are used to estimate future contingent earnout payments, which are discounted back to present value to compute contingent earnout liabilities. The following table provides a roll-forward from June 30, 2023 to March 31, 2024 of the contingent consideration liability, which is included in other accrued expenses and current liabilities and other long-term liabilities in our consolidated balance sheets (in thousands):
Beginning fair value, June 30, 2023
$
21,181
Addition of contingent earnout obligations
1,766
Foreign currency translation adjustment
( 14 )
Changes in fair value for contingent earnout obligations
( 3,443 )
Payments on contingent earnout obligations
( 602 )
Ending fair value, March 31, 2024
$
18,888
20
Table of Contents
Environmental Contingencies
We are subject to various environmental laws. We conduct environmental investigations at our manufacturing facilities in North America, Asia-Pacific, and Europe, and, to the extent practicable, on all new properties in order to identify, as of the date of such investigation, potential areas of environmental concern related to past and present activities or from nearby operations. In certain cases, we have conducted further environmental assessments consisting of soil and groundwater testing and other investigations deemed appropriate by independent environmental consultants.
We have not accrued for loss contingencies relating to environmental matters because we believe that, although unfavorable outcomes are possible, they are not considered by our management to be probable and reasonably estimable. If one or more of these environmental matters are resolved in a manner adverse to us, the impact on our business, financial condition, results of operations and cash flow could be material.
Indemnifications and Certain Employment-Related Contingencies
In the normal course of business, we have agreed to indemnify certain parties with respect to certain matters. We have agreed to hold certain parties harmless against losses arising from breaches of representations, warranties or covenants, or intellectual property infringement or other claims made by third parties. These agreements may limit the time within which an indemnification claim can be made and the amount of the claim. In addition, we have entered into indemnification agreements with our directors and certain of our officers. It is not possible to determine the maximum potential liability amount under these indemnification agreements due to, among other things, the limited history of prior indemnification claims and the unique facts and circumstances involved in each particular agreement. We have not recorded any liability for costs related to contingent indemnification obligations as of March 31, 2024.
On December 31, 2017, we and Deepak Chopra, our Chief Executive Officer, entered into an amendment to Mr. Chopra’s employment agreement that, among other things, provided for a $ 13.5 million bonus payment to Mr. Chopra on or within 45 days of January 1, 2024. This amount was included in accrued payroll and related expenses as of December 31, 2023 and was paid in full in February 2024.
Product Warranties
We offer our customers warranties on many of the products that we sell. These warranties typically provide for repairs and maintenance of the products if problems arise during a specified time period after original shipment. Concurrent with the sale of products, we record a provision for estimated warranty expenses with a corresponding increase in cost of goods sold. We periodically adjust this provision based on historical experience and anticipated expenses. We charge actual expenses of repairs under warranty, including parts and labor, to this provision when incurred. The current obligation for warranty provision is included in other accrued expenses and current liabilities and the noncurrent portion is included in other long-term liabilities in the consolidated balance sheets.
The following table presents changes in warranty provisions (in thousands):
Nine Months Ended March 31,
2023
2024
Balance at beginning of period
$
13,347
$
11,149
Additions
2,622
3,524
Reductions for warranty repair costs and adjustments
( 5,831 )
( 4,145 )
Balance at end of period
$
10,138
$
10,528
Legal Proceedings
In February 2023, one of our subsidiaries received a subpoena from the U.S. Department of Justice (“DoJ”). The subpoena was issued as part of a DoJ case against a former employee of an OSI Systems subsidiary for embezzlement and other conduct occurring before he was hired by our subsidiary and while he was employed by another company in the United States and Mexico. The subpoena requests documents and records relating to, among other things, the former employee and the Company’s business dealings in Mexico since 2020. In February 2024, we received a follow-up subpoena requesting the same categories of documents but extending the relevant time period through to the date of the second subpoena. We have produced documents in response to these subpoenas and intend to cooperate with any further subpoenas or other requests in connection with this or any ensuing investigation.
21
Table of Contents
We are involved in various other potential or actual claims and legal proceedings arising in the ordinary course of business. In our opinion after consultation with legal counsel, the ultimate disposition of such proceedings is not likely to have a material adverse effect on our business, financial condition, results of operations or cash flows. We have not accrued for loss contingencies relating to any non-ordinary course matters because we believe that, although unfavorable outcomes in the proceedings are possible, they are not considered by management to be probable and reasonably estimable. If one or more of these matters are resolved in a manner adverse to our company, the impact on our business, financial condition, results of operations and cash flows could be material.
11. Income Taxes
The determination of the annual effective tax rate is based upon a number of significant estimates and judgments, including the estimated annual pretax income in each tax jurisdiction in which we operate and the development of tax planning strategies during the year. In addition, as a global commercial enterprise, our tax expense can be impacted by changes in tax rates or laws, the finalization of tax audits and reviews and other factors that cannot be predicted with certainty. As such, there can be significant volatility in interim tax provisions.
The effective tax rates for the three months ended March 31, 2023 and 2024 were 23.8 % and 22.6 %, respectively. During the three months ended March 31, 2024, we recognized a net discrete tax benefit of $ 0.2 million related to equity-based compensation under ASU 2016-09 and changes in prior year tax estimates. During the three-month period ended March 31, 2023, we recognized a net discrete tax expense of $ 0.2 million related to equity-based compensation under ASU 2016 - 09 and changes in prior year tax estimates.
The effective tax rates for the nine months ended March 31, 2023 and 2024 were 22.6 % and 21.7 %, respectively. During the nine months ended March 31, 2024, we recognized net discrete tax benefits of $ 0.8 million related to equity-based compensation under ASU 2016-09 and $ 2.3 million for changes in prior year tax estimates. During the nine months ended March 31, 2023, we recognized a net discrete tax benefit of $ 0.6 million related to equity-based compensation under ASU 2016-09 and changes in prior year tax estimates.
12. Segment Information
We have determined that we operate in three identifiable industry segments: (a) security and inspection systems (Security division), (b) optoelectronic devices and manufacturing (Optoelectronics and Manufacturing division) and (c) medical monitoring systems (Healthcare division). We also have a corporate segment (Corporate) that includes executive compensation and certain other general and administrative expenses, expenses related to stock issuances and legal, audit and other professional service fees not allocated to industry segments. Both the Security and Healthcare divisions comprise primarily end-product businesses, whereas the Optoelectronics and Manufacturing division primarily supplies components and subsystems to external OEM customers, as well as to the Security and Healthcare divisions. Sales between divisions are at transfer prices that approximate market values. All other accounting policies of the segments are the same as described in Note 1, Basis of Presentation.
22
Table of Contents
The following tables present our results of operations and identifiable assets by industry segment (in thousands):
Three Months Ended
Nine Months Ended
March 31,
March 31,
2023
2024
2023
2024
Revenues (1) —by Segment:
Security division
$
178,752
$
285,960
$
491,188
$
700,564
Optoelectronics and Manufacturing division, including intersegment revenues
93,888
87,974
286,513
282,199
Healthcare division
43,911
41,493
130,994
121,130
Intersegment revenues elimination
( 13,662 )
( 10,021 )
( 42,138 )
( 46,042 )
Total
$
302,889
$
405,406
$
866,557
$
1,057,851
Income (loss) from operations —by Segment:
Security division
$
29,496
$
50,127
$
66,014
$
122,592
Optoelectronics and Manufacturing division
12,493
9,435
35,963
32,493
Healthcare division
1,787
1,564
4,819
2,157
Corporate
( 10,148 )
( 9,733 )
( 29,572 )
( 30,832 )
Intersegment eliminations
709
( 30 )
904
( 167 )
Total
$
34,337
$
51,363
$
78,128
$
126,243
June 30,
March 31,
2023
2024
Assets (2) —by Segment:
Security division
$
948,126
$
1,231,843
Optoelectronics and Manufacturing division
310,930
245,746
Healthcare division
245,856
298,027
Corporate
94,678
101,804
Eliminations (3)
( 43,904 )
( 46,345 )
Total
$
1,555,686
$
1,831,075
(1) For the three months ended March 31, 2023, one Security division customer accounted for 13 % of net revenues while no customers represented over 10 % of net revenues for the nine months ended March 31, 2023. For the three months ended March 31, 2024, one Security division customer accounted for 26 % of net revenues. For the nine months ended March 31, 2024, two Security division customers accounted for 13 % and 12 % of net revenues, respectively.
(2) As of June 30, 2023, no customer accounted for greater than 10 % of accounts receivable, net. As of March 31, 2024, two customers in the Security division accounted for 27 % and 14 %, respectively, of accounts receivable, net.
(3) Eliminations in assets reflect the amount of inter-segment profits in inventory and inter-segment ROU assets under ASC 842 as of the balance sheet date. Such inter-segment profit will be realized when inventory is shipped to the external customers of the Security and Healthcare divisions.
23
Table of Contents